Dr. Andrew Loblaw
@DrAndrewLoblaw
Head of GU, Prostate Ca researcher @Sunnybrook. Committed to a Cure in Your Lifetime, putting patients 1st, doing more for less. Tweets my own https://t.co/0C8OAqBJz8
20-04-2013 13:29:11
8,4K Tweets
3,2K Followers
1,1K Following
Agree Ian Davis and now that relugolix is now in π¨π¦ we now struggle with optimal duration of ADT.
If giving 4mo ADT for unfav int risk or 8mo for IAB do we give the same duration of relugolix or 50% longer?
What do you do Daniel E Spratt Chris Parker Shankar Siva Amar Kishan